CRISIL Ltd. Valuation Shifts Signal Changing Market Sentiment

Valuation Metrics and Recent Changes

As of 23 Sep 2026, CRISIL's price-to-earnings (P/E) ratio stands at 37.30, a figure that, while still elevated, marks a moderation from previous levels that classified the stock as very expensive. The price-to-book value (P/BV) ratio is currently 10.08, underscoring the premium investors are willing to pay for the company's net assets. Other valuation multiples such as EV to EBIT (30.00) and EV to EBITDA (26.36) remain high, consistent with the company's strong market position and profitability metrics.

These valuation figures contrast with peers in the capital markets industry. CARE Ratings, for instance, holds a 'very expensive' valuation status with a P/E of 27.55 and EV to EBITDA of 23.37, while ICRA is rated 'expensive' with a P/E of 22.38 and EV to EBITDA of 15.86. CRISIL's higher multiples reflect its superior return on capital employed (ROCE) of 40.16% and return on equity (ROE) of 27.03%, which justify a premium but also raise questions about sustainability at current price levels.

Price Performance and Market Context

CRISIL's current market price is ₹4,565.85, down 1.01% from the previous close of ₹4,612.25. The stock has traded within a 52-week range of ₹3,689.00 to ₹5,060.00, indicating significant volatility over the past year. Notably, the stock's one-week return is -0.54%, slightly underperforming the Sensex's 0.71% gain. However, over the one-month horizon, CRISIL has outperformed with a 1.17% gain compared to the Sensex's 3.88% decline.

Year-to-date, CRISIL has delivered a 5.56% return, outperforming the Sensex's negative 12.55% return, signalling resilience amid broader market weakness. Over longer periods, the stock has demonstrated robust growth, with a three-year return of 18.49% versus the Sensex's 12.91%, and a five-year return of 57.06% compared to the benchmark's 26.48%. However, the ten-year return of 108.84% trails the Sensex's 159.02%, suggesting that while CRISIL has been a strong performer, it has not matched the broader market's long-term gains.

Mojo Score and Rating Revision

MarketsMOJO has revised CRISIL's Mojo Grade from 'Buy' to 'Hold' as of 07 Sep 2026, reflecting the stock's changing valuation landscape and the need for cautious investor appraisal. The current Mojo Score stands at 65.0, indicating moderate confidence in the stock's near-term prospects. This downgrade aligns with the shift in valuation grade from 'very expensive' to 'expensive', signalling that while CRISIL remains a quality company, its price appreciation potential may be limited at current levels.

Comparative Valuation Analysis

When analysing CRISIL's valuation in the context of its peers, it is evident that the company commands a premium. Its P/E ratio of 37.30 is significantly higher than CARE Ratings' 27.55 and ICRA's 22.38. Similarly, the EV to EBITDA multiple of 26.36 surpasses CARE's 23.37 and ICRA's 15.86. This premium is supported by CRISIL's superior profitability metrics, including a ROCE of 40.16% and ROE of 27.03%, which are among the highest in the sector.

However, the PEG ratio of 1.73, while indicating growth expectations, is higher than CARE Ratings' 1.14 but lower than ICRA's 1.98, suggesting that the market anticipates steady but not explosive growth for CRISIL. The dividend yield of 1.40% is modest, reflecting the company's focus on reinvestment and growth rather than income distribution.

Implications for Investors

The shift in valuation grade and the Mojo Grade downgrade to 'Hold' suggest that investors should carefully weigh CRISIL's premium pricing against its growth prospects and sector dynamics. While the company boasts strong fundamentals and has outperformed the Sensex over medium-term horizons, the elevated multiples imply limited margin for error. Any slowdown in earnings growth or adverse market conditions could pressure the stock's valuation.

Investors may consider monitoring upcoming quarterly results and sector developments closely. The current price range between ₹4,510.65 and ₹4,675.00 on the day of analysis indicates some volatility, which could present tactical entry or exit points depending on broader market trends.

Historical Performance Versus Market Benchmarks

CRISIL's long-term performance relative to the Sensex reveals a nuanced picture. While the stock has delivered a 57.06% return over five years, more than double the Sensex's 26.48%, its ten-year return of 108.84% lags behind the Sensex's 159.02%. This suggests that CRISIL's growth trajectory has accelerated in recent years, possibly driven by sector tailwinds and company-specific initiatives.

Shorter-term returns show mixed results. The one-year return of -7.75% slightly outperforms the Sensex's -9.29%, and the year-to-date gain of 5.56% contrasts favourably with the Sensex's -12.55%. These figures highlight CRISIL's relative resilience amid broader market volatility, although the recent one-week decline of 0.54% indicates some near-term pressure.

Conclusion: Valuation Attractiveness Moderates Amid Strong Fundamentals

CRISIL Ltd. remains a leading entity in the capital markets sector with robust profitability and growth metrics. However, the recent shift in valuation grading from very expensive to expensive, coupled with a Mojo Grade downgrade to Hold, signals a moderation in price attractiveness. Investors should balance the company's strong fundamentals against its premium valuation multiples and consider peer comparisons carefully.

Given the current market environment and CRISIL's valuation profile, a cautious approach is warranted. While the stock has demonstrated resilience and outperformance over medium-term periods, the elevated P/E and P/BV ratios suggest limited upside without corresponding earnings acceleration. Monitoring sector trends and company earnings will be critical for investors seeking to optimise their exposure to CRISIL.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today